Literature DB >> 16232010

Bipolar disorder: quality of life and the impact of atypical antipsychotics.

Lana A Vornik1, Robert M A Hirschfeld.   

Abstract

This article reviews the impact of bipolar disorder on the quality of life of affected individuals. In particular, the impact of atypical antipsychotics on the quality of life of individuals with bipolar disorder is addressed. Among atypical antipsychotics, olanzapine has been studied most with regard to quality of life. In general, symptomatic improvements have been associated with improvements in quality of life.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232010

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  5 in total

1.  A Canadian naturalistic study of a community-based cohort treated for bipolar disorder.

Authors:  Doron Sagman; Bobbie Lee; Ranjith Chandresena; Barry Jones; Elizabeth Brunner
Journal:  BMC Psychiatry       Date:  2010-03-19       Impact factor: 3.630

2.  Adaptation and validation of the "tolerability and quality of life" (TOOL) questionnaire in Chinese bipolar patients.

Authors:  Lin Xiao; Yulin Gao; Lili Zhang; Peiyun Chen; Xiaojia Sun; Siyuan Tang
Journal:  Qual Life Res       Date:  2016-05-23       Impact factor: 4.147

3.  Ziprasidone in the treatment of mania in bipolar disorder.

Authors:  Stephen E Nicolson; Charles B Nemeroff
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

4.  Quetiapine monotherapy for bipolar depression.

Authors:  Michael E Thase
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

5.  Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL).

Authors:  Judit Simon; John R Geddes; Alexandra Gardiner; Jennifer Rendell; Guy M Goodwin; Susanne Mayer
Journal:  Bipolar Disord       Date:  2018-12-17       Impact factor: 6.744

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.